Novo-Nordisk A/S (NVO)
Underlying price
$39.84-7.86% today
Stock stats
- Market cap
- $191B
- Previous close
- $43.24
- Open
- $41.05
- Day's range
- $39.54 – $41.17
- 52-week range
- $35.12 – $64.16
- Volume
- 48.4M
- Avg volume
- 11.5M
- P/E ratio
- -
About Novo-Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
- Ticker
- NVO
- Asset class
- Equity
- Tokenized by
- 2 issuers
- Employees
- 69,500
- Website
- novonordisk.com
Novo-Nordisk A/S FAQ
NVO is Novo-Nordisk A/S stock, issued on Solana as a token that tracks the listed share. Each issuer mints its own version, so Novo-Nordisk A/S trades here as 2 tokens rather than one.